AN2 Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AN2 Therapeutics generated cash of -$53,288,000, which is less than the previous year. Cash used in financing activities reached the amount of $84,994,000 last year. Net change in cash is therefore -$11,572,000.
Cash Flow
| 2019 | -2.48M | 0 | 8.08M |
|---|---|---|---|
| 2020 | -5.36M | 0 | 3.83M |
| 2021 | -20.48M | -50.02M | 78.53M |
| 2022 | -33.46M | -21.77M | 70.35M |
| 2023 | -53.28M | -43.27M | 84.99M |
ANTX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 27.21M | 12.09M | 4.07M | 5.59M | 0 |
Operating activities | |||||
Net income | -64.73M | -40.95M | -21.54M | -13.60M | -5.63M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | -692K | 0 | 0 | 0 |
Stock-based compensation expense | 8.41M | 4.39M | 974K | 40K | 0 |
| Deferred income tax benefit | 8.41M | 4.39M | 974K | 40K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 553K | 2.49M | 417K | 81K | -16K |
Cash generated by operating activities | -53.28M | -33.46M | -20.48M | -5.36M | -2.48M |
Investing activities | |||||
Purchases Of Investments | -132.17M | -93.83M | -77.27M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -43.27M | -21.77M | -50.02M | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 84.52M | 70.36M | 78.53M | 3.83M | 8.08M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -11K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 84.99M | 70.35M | 78.53M | 3.83M | 8.08M |
Net Change In Cash | -11.57M | 15.12M | 8.02M | -1.52M | 5.59M |
Cash at end of period | 15.64M | 27.21M | 12.09M | 4.07M | 5.59M |
| Data source | Data source |